Department of Neurosurgery, Yale School of Medicine, New Haven, CT 06510, USA.
Curr Oncol. 2022 Feb 24;29(3):1408-1421. doi: 10.3390/curroncol29030118.
Craniopharyngiomas are rare, benign primary brain tumors that arise from remnants of the craniopharyngeal duct epithelium within the sellar and suprasellar region. Despite their benign biology, they may cause significant morbidity, secondary to involvement of nearby eloquent neural structures, such as the pituitary gland, hypothalamus, and optic apparatus. Historically, aggressive surgical resection was the treatment goal to minimize risk of tumor recurrence via open transcranial midline, anterolateral, and lateral approaches, but could lead to clinical sequela of visual, endocrine, and hypothalamic dysfunction. However, recent advances in the endoscopic endonasal approach over the last decade have mostly supplanted transcranial surgery as the optimal surgical approach for these tumors. With viable options for adjuvant radiation therapy, targeted medical treatment, and alternative minimally invasive surgical approaches, the management paradigm for craniopharyngiomas has shifted from aggressive open resection to more minimally invasive but maximally safe resection, emphasizing quality of life issues, particularly in regards to visual, endocrine, and hypothalamic function. This review provides an update on current multi-modal approaches for craniopharyngiomas, highlighting the modern surgical treatment paradigm for this disease entity.
颅咽管瘤是一种罕见的良性原发性脑肿瘤,起源于鞍区和鞍上区域颅咽管上皮的残余物。尽管它们具有良性生物学特性,但由于涉及附近的重要神经结构,如垂体、下丘脑和视神经,可能会导致严重的发病率。历史上,积极的手术切除是治疗目标,通过开颅中线、前外侧和外侧入路,最大限度地降低肿瘤复发的风险,但可能导致视觉、内分泌和下丘脑功能障碍的临床后遗症。然而,在过去十年中,内镜经鼻入路的进步在很大程度上取代了开颅手术,成为这些肿瘤的最佳手术入路。由于辅助放疗、靶向药物治疗和替代微创外科手术方法的可行选择,颅咽管瘤的治疗模式已经从积极的开放性切除转变为更微创但最大限度地安全切除,强调生活质量问题,特别是在视觉、内分泌和下丘脑功能方面。本文综述了颅咽管瘤的当前多模态治疗方法,强调了这种疾病实体的现代手术治疗模式。